Das, Suradip
Hilman, Melanie C.
Yang, Feikun
Mourkioti, Foteini
Yang, Wenli
Cullen, D. Kacy
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-19-1-0867)
National Institutes of Health (R01-NS117757)
Article History
Received: 8 August 2023
Accepted: 30 January 2024
First Online: 7 March 2024
Declarations
:
: Not applicable.
: D. K. C. is a co-founder of Axonova Medical, LLC, and Innervace, Inc., which are University of Pennsylvania spin-out companies focused on translation of advanced regenerative therapies to treat nervous system disorders. US Patent Application 17/291,869 and PCT International Patent Application PCT/US2019/060585 titled “Engineering of Innervated Tissue and Modulation of Peripheral Organ Activity” (D. K. C, SD) are related to the techniques described in this paper. The other authors declare that they have no competing interests.